Advanced Single Cell Visualization Suite for Genomic Research

elucidataelucidata
1 min read

Single Cell Analytics Evolution

Single-cell analytics focuses on individual cells to study the unique characteristics and cellular heterogeneity which often gets masked in bulk analyses. It uses multi-omics techniques like scRNA-seq, single-cell ATAC-seq, proteomics, and metabolomics to reveal gene expression, chromatin accessibility, protein dynamics, and metabolic states. The applications range from the identification of rare cell types and subpopulations to cellular processes like development, disease progression, and drug responses. Single-cell analytics also integrates machine learning for pattern recognition and dynamic modeling to accelerate research in fields like personalized medicine, regenerative therapies, and drug discovery. (1)

Advancements in technologies like droplet-based sequencing, spatial transcriptomics, and multimodal profiling have accelerated the growth of single-cell genomics. These methods are capable of generating vast datasets containing millions of data points, each representing a unique combination of gene expression, spatial context, and other molecular characteristics. However, the analytical and visualization landscape for this data has struggled to keep pace with the scale and complexity of these datasets.
Source Url

0
Subscribe to my newsletter

Read articles from elucidata directly inside your inbox. Subscribe to the newsletter, and don't miss out.

Written by

elucidata
elucidata

Website: https://www.elucidata.io/ Elucidata leverages its platform, Polly to augment the quality of data in pre-clinical drug discovery. It curates multi-omics and assay data to make them ML-ready or analysis-ready. Our exceptional multi-disciplinary team of experts use Polly’s powerful curation engine to harmonize a diverse array of data-types, curate metadata and process data consistently at affordable costs while maintaining information-richness. We are one of the only companies to offer a tech-enabled approach to multi-modal data curation that serves the life science industry. Polly’s technology and experts have helped R&D teams arrive at multiple validated drug targets across immunology, oncology, and metabolomic disorders. Currently, 25+ research organizations, including 4 of the largest 10 pharma companies are using Polly and its allied solutions to accelerate their discovery programs. Many other data-driven healthcare companies also use Polly to process, harmonize and store public or in-house biomedical data. Address: 114 Sansome Street, Suite 250 San Francisco, CA 94104 Phone No: 9716140329 Contact Email: info@elucidata.io